Lartesertib
Lartesertib is a potent and selective ATM kinase inhibitor used in cancer research. It is employed in vitro and in vivo to study DNA damage response pathways, particularly in the context of non-small cell lung cancer and other malignancies.
Product Specifications
CAS Number
2495096-26-7
Product Name Alternative
ATR, ATM Inhibitor-5, ATM, M4076
Field of Research
Cell Biology, Immunology & Inflammation, Molecular Biology, Signal Transduction
Purity
99.90% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (7.36 mM) ; DMSO:80 mg/mL (178.39 mM)
Smiles
COc1cncc (F) c1-n1c2c (cnc3cc (OC) c (cc23) -c2cn (C) nc2C) n (C) c1=O
Molecular Formula
C23H21FN6O3
Molecular Weight
448.45
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS718922-01 0.02 mg (E-Coli)
Recombinant Human Proteasome subunit alpha type-3 (PSMA3)
Sign In for Pricing
View Details MBS718922-02 0.1 mg (E-Coli)
Recombinant Human Proteasome subunit alpha type-3 (PSMA3)
Sign In for Pricing
View Details MBS718922-03 0.02 mg (Yeast)
Recombinant Human Proteasome subunit alpha type-3 (PSMA3)
Sign In for Pricing
View Details MBS718922-04 0.1 mg (Yeast)
Recombinant Human Proteasome subunit alpha type-3 (PSMA3)
Sign In for Pricing
View Details MBS718922-05 0.02 mg (Baculovirus)
Recombinant Human Proteasome subunit alpha type-3 (PSMA3)
Sign In for Pricing
View Details MBS718922-06 0.02 mg (Mammalian-Cell)
Recombinant Human Proteasome subunit alpha type-3 (PSMA3)
Sign In for Pricing
View Details